KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tenet Healthcare (THC) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Tenet Healthcare (THC) over the last 17 years, with Q4 2025 value amounting to $205.0 million.

  • Tenet Healthcare's Interest Expenses rose 98.52% to $205.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $821.0 million, marking a year-over-year decrease of 60.53%. This contributed to the annual value of $821.0 million for FY2025, which is 60.53% down from last year.
  • Tenet Healthcare's Interest Expenses amounted to $205.0 million in Q4 2025, which was up 98.52% from $206.0 million recorded in Q3 2025.
  • Tenet Healthcare's Interest Expenses' 5-year high stood at $240.0 million during Q1 2021, with a 5-year trough of $202.0 million in Q3 2024.
  • In the last 5 years, Tenet Healthcare's Interest Expenses had a median value of $221.0 million in 2021 and averaged $218.0 million.
  • Its Interest Expenses has fluctuated over the past 5 years, first tumbled by 1368.82% in 2021, then soared by 365.3% in 2023.
  • Over the past 5 years, Tenet Healthcare's Interest Expenses (Quarter) stood at $221.0 million in 2021, then decreased by 0.9% to $219.0 million in 2022, then rose by 3.65% to $227.0 million in 2023, then dropped by 10.57% to $203.0 million in 2024, then rose by 0.99% to $205.0 million in 2025.
  • Its Interest Expenses stands at $205.0 million for Q4 2025, versus $206.0 million for Q3 2025 and $206.0 million for Q2 2025.